NaviCam™
External Control of Medical Robotic Capsules

Inside The Human Body

See How We Do It

About Our Company

AnX Robotica’s NaviCam™ System has achieved a medical milestone by enabling the ability to do a gastroscopy examination with a non-invasive, patient-friendly procedure while giving the physician complete control. By simply swallowing a pill-sized gastroscopy capsule, patients can undergo a thorough stomach examination in approximately 15 minutes with no sedation or invasive procedures. The technology has been utilized in over a half-million patients worldwide including over 200,000 patients in 2019.

AnX Robotica Corporation, founded in 2019 is an advanced technology medical device company integrating innovative research and development with the mission of providing the medical community with patient-friendly devices for diagnostic and therapeutic applications. AnX products include the “Magnetically Controlled Robotic Capsule Endoscope”.

Learn More About Us

The First Robotic Magnetically Controlled Capsules Of Their Kind

The new generation of radiopaque markers with improved visibility on X-rays.

Learn More

IntraMarX™

Radiopaque Markers

The first robotically controlled capsule for visualization of the stomach.

Learn More

NaviCam™ Stomach

Capsule System

NaviCam™ SB with NaviCam Engine™ - Small Bowel Capsule Endoscopy with Intelligent Reading Support.

Learn More

NaviCam™ SB

Capsule System

Complete examination of the esophagus, stomach and small intestine.

Learn More

NaviCam™ UGI

Capsule System

The AnX Robotica Vibrating Capsule mechanically stimulates peristalsis in the large intestine for treatment of constipation.

Learn More

VibraBot™

Capsule

High frame rate dual-camera enables NaviCam™ Colon Capsule to be a minimally invasive tool for visualization of the colon.

Learn More

NaviCam™ Colon

Capsule System

Keeping Up With

AnX ROBOTICA

What’s happening at AnX Robotica Corp? Learn more about the latest news and keep current with the most up-to-date information about our products.

Visit Our Newsroom